Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1782PDF: 836HTML: 179 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1509PDF: 799Suppl. Files: 334Html: 141 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2340PDF: 1192HTML: 660 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1590PDF: 807HTML: 222 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4870PDF: 1836HTML: 2169 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
232PDF: 259Suppl. Files: 47HTML: 53 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1210PDF: 775HTML: 1484Figure 1: 196Figure 2: 198 -
Osteolytic bone lesions – A rare presentation of AML M6.
2019PDF: 1124HTML: 7953Untitled: 207 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2915PDF: 1126HTML: 3038 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2680PDF: 763HTML: 2318 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1132PDF: 452HTML: 254 -
How I treat acute and persistent sickle cell pain
1998PDF: 1131HTML: 493 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1093PDF: 1185HTML: 101 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1299PDF: 779HTML: 322 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3401PDF: 2291HTML: 23375Untitled: 210Untitled: 223Untitled: 241 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1420PDF: 562HTML: 212 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2079PDF: 782HTML: 3119 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1433PDF: 836HTML: 3125 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12461PDF: 1694HTML: 4218Cover letter: 206Figure 1: 214 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1667PDF: 602HTML: 238 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3616PDF: 1522HTML: 4441CoverLetter: 190Figure1: 204







